Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CENTENE CORPORATION

(CNC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Centene Corporation Announces Executive Changes

07/15/2021 | 07:00am EDT

Centene Corporation announced that Colin Toney, Senior Vice President, Enterprise Strategy Group, has been appointed to Executive Vice President, Mergers and Acquisitions, effective immediately. Mr. Toney will report to Chairman, President, and CEO Michael Neidorff. On July 12, 2021, Jesse Hunter, Executive Vice President and Chief Strategy Officer, notified the Company of his intent to resign from his position effective July 31, 2021, and will provide transition support continuing through December 31, 2021. Before joining Centene, Mr. Toney worked at Allen & Company, advising companies in healthcare, technology, media, and other industries on mergers and acquisitions and capital raising. Mr. Toney executed over 25 closed M&A transactions representing over $30 billion, including working with Centene on the Health Net and Fidelis Care acquisitions. Before joining Allen & Company, Mr. Toney worked in M&A at the investment banking firm Stephens Inc.


© S&P Capital IQ 2021
All news about CENTENE CORPORATION
09/15WALL STREET STOCK EXCHANGE : Yes, the global economic recovery is slowing
09/15ANALYST RECOMMENDATIONS : Chevron, Centene, Darktrace, Flutter, Malibu Boats...
09/14CENTENE : Mizuho Securities Adjusts Centene PT to $75 From $67, Maintains Neutra..
MT
09/14CENTENE : Morgan Stanley Adjusts Centene's Price Target to $79 from $88, Keeps O..
MT
09/14CENTENE : Credit Suisse Adjusts Price Target for Centene to $70 From $73.50, Mai..
MT
09/14REMINDER : Centene Corporation's 2021 Third Quarter Financial Results Conference..
PR
09/08CENTENE : Bernstein Adjusts Centene's Price Target to $92 from $102, Keeps Outpe..
MT
09/08CENTENE : Mizuho Securities Adjusts Centene PT to $67 From $75, Maintains Neutra..
MT
09/07RITE AID : Subsidiary Elixir Names Lance Neill Chief Operating Officer
MT
09/07CENTENE : BRENT LAYTON NAMED PRESIDENT AND CHIEF OPERATING OFFICER (Form 8-K)
PU
More news
Analyst Recommendations on CENTENE CORPORATION
More recommendations
Financials (USD)
Sales 2021 125 B - -
Net income 2021 1 191 M - -
Net Debt 2021 9 280 M - -
P/E ratio 2021 30,7x
Yield 2021 -
Capitalization 35 910 M 35 910 M -
EV / Sales 2021 0,36x
EV / Sales 2022 0,35x
Nbr of Employees 71 300
Free-Float 96,0%
Chart CENTENE CORPORATION
Duration : Period :
Centene Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CENTENE CORPORATION
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 19
Last Close Price 61,59 $
Average target price 84,58 $
Spread / Average Target 37,3%
EPS Revisions
Managers and Directors
Michael F. Neidorff Chairman & Chief Executive Officer
Brent Davis Layton President & Chief Operating Officer
Andrew Lynn Asher Chief Financial Officer & Executive Vice President
Mary V. Mason Chief Medial Officer & Senior Vice President
Ken Yamaguchi Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capi. (M$)
CENTENE CORPORATION2.60%35 933
UNITEDHEALTH GROUP17.64%393 687
ANTHEM, INC.14.13%91 314
CIGNA CORPORATION-2.18%70 259
HUMANA INC.-2.02%51 530
MOLINA HEALTHCARE, INC.25.12%15 541